CoChat

The effect of orlistat on weight reduction in obese and overweight Korean patients

Ahn, Soo Mi, Kim, Hyunah, Ji, Eunhee, Han, Nayoung, Oh, Jung Mi · 2014 · Archives of Pharmacal Research

The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.

Abstract

Obesity is a chronic metabolic disease that affects an increasing number of people around the world. There have been limited studies evaluating the weight loss effects of orlistat in the Korean population, whose diet is different from that of the Caucasian population. The primary objective of this study was to evaluate the effect of orlistat on the weight and body mass index of obese and overweight Korean patients. The secondary objective was to evaluate the effects of orlistat on risk factors for obesity and metabolic disorders. Obese adult patients with a body mass index greater than 25 kg/m(2) who received 120 mg of orlistat three times daily for 24 weeks were included in this study. Patients were retrospectively evaluated for changes in body weight and body mass index, as well as waist and hip circumference, body fat levels, serum lipid levels, fasting glucose levels, and blood pressure. The evaluation included 63 patients. Treatment with orlistat for 4, 12, or 24 weeks significantly decreased the weight, body mass index, waist circumference, and hip circumference compared to that at the baseline. The average weight loss was 3.0 kg at 12 weeks and 3.6 kg at 24 weeks, which indicated a 3.8 and 4.6 % decrease from initial weight, respectively. The number of patients who lost more than 10 % of their initial body weight was 3 (4.8 %) at 12 weeks and 27 (7.9 %) at 24 weeks. About 27 % of patients reported gastrointestinal-related adverse effects with orlistat, but no serious a…

Overview

Integrity signals

Registry

Crossref · 10.1007/s12272-013-0201-8

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. Chon, S., C. Park, G. Koh, S. Oh, J.T. Woo, S.W. Kim, J.W. Kim, Y.S. Kim, H.Y. Son, B.Y. Cha, K.H. Yoon, H.S. Kwon, B.S. Cha, and H.C. Lee. 2004. The effect of orlistat in obese patients with type 2 diabetes: Benefit on abdominal obesity and glycemic control. Journal of Korean Society for the Study of Obesity 13: 281–292.

Cited by

See all 14

Metadata

Authors
Ahn, S. M., Kim, H., Ji, E., Han, N., & Oh, J. M.
Affiliations
  • Sookmyung Women's University (KR)
  • Gachon University (KR)
  • Seoul National University (KR)
Corresponding author
Oh, Jung Mi
Venue
Archives of Pharmacal Research
Published
2013-07-10
Volume
37
Issue
4
Pages
512-519
ISSN
  • 0253-6269 (ISSN-L)
  • 1976-3786
OpenAlex
W1995475244
Cited by
14
References
28
Citations by year
2024: 7 · 2023: 1 · 2021: 1 · 2019: 1 · 2018: 1 · 2015: 1 · 2014: 1
FWCI
0.49
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Archives of Pharmacal Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
Keywords
orlistat, weight loss, obesity, overweight, Korean patients, body mass index, waist circumference, serum lipids, fasting blood glucose, blood pressure, gastrointestinal adverse effects, anti-obesity drugs
MeSH terms
Orlistat, Adipose Tissue, Blood Glucose, Blood Pressure, Fasting, Female, Humans, Lactones, Lipids, Male, Middle Aged, Obesity, Risk Factors, Weight Loss, Body Mass Index, Asian People, Waist-Hip Ratio, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of orlistat on weight reduction in obese and overweight Korean patients. https://app.cochat.ai/papers/10.1007/s12272-013-0201-8
The paper
Ahn, S. M., Kim, H., Ji, E., Han, N., & Oh, J. M. (2014). The effect of orlistat on weight reduction in obese and overweight Korean patients. Archives of Pharmacal Research. https://doi.org/10.1007/s12272-013-0201-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.